HUMAW (HUMAW) Stock Price & Analysis
HUMAW (HUMAW) fell 78.05% to USD 0 as of September 9, 2026 at 12:53 UTC, according to Nexqual real-time market data.
HUMAW last closed at USD 0; the session ranged USD 0–0 on volume of 258,659 shares. Market capitalization is —, with a 52-week range of USD 0–0 (NMS). Source: Nexqual, September 9, 2026 at 12:53 UTC.
Key Statistics (as of September 9, 2026 at 12:53 UTC)
| Price | USD 0 |
|---|---|
| Change | ▼ 78.05% (down) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 258,659 shares |
| Market Cap | — |
| Exchange | NMS |
From HUMAW's Latest SEC 10-K Filing (filed 2026-03-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CELUW | Celularity Inc. | USD 0 | ▲ 0% |
| JSPRW | Jasper Therapeutics, Inc. | USD 0.01 | ▼ 19.57% |
| SRZNW | Surrozen, Inc. Warrant | USD 0 | ▲ 153.33% |
| HUMA | Humacyte, Inc. | USD 0.59 | ▼ 0.18% |
| SABSW | SAB Biotherapeutics, Inc. | USD 0.02 | ▼ 22.88% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 12:53 UTC. This page is informational and not investment advice.